Elite Pharma (ELTP) Files 8-K/A to Correct Earnings Call Date
ELITE PHARMACEUTICALS INC /NV/
Subscribe to track ELTP
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Elite Pharma (ELTP) Files 8-K/A to Correct Earnings Call Date
Company: ELITE PHARMACEUTICALS INC /NV/ (ELTP) Form: 8-K/A | Filed: 2025-11-12 Significance: Low
Filing Summary: This filing is a minor administrative amendment to a Current Report on Form 8-K filed on November 10, 2025. The sole purpose is to correct the date of the upcoming conference call.
Key Insight: The company is correcting the date for its conference call to discuss Q2 2026 financial results. The call is now correctly scheduled for Monday, November 17, 2025, at 11:30 AM EST. This is a routine procedural filing with no new material information.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Elite Pharmaceuticals, Inc. (ELTP)
Executive Summary
- Trading Significance: Low
- Key Takeaway: This is a minor administrative filing to correct the date of a previously announced earnings conference call. It contains no new material financial or operational information.
- Market Impact: Neutral. This type of procedural correction is not expected to influence trading activity.
Filing Information
| Field | Value |
|---|---|
| Company | ELITE PHARMACEUTICALS INC /NV/ |
| Ticker Symbol | ELTP |
| CIK | 0001053369 |
| Form Type | 8-K/A |
| Filing Date | 2025-11-12 |
Analysis
Elite Pharmaceuticals filed a Form 8-K/A (an amendment to a prior 8-K) for the sole purpose of correcting information related to its upcoming earnings conference call.
- Original Filing: An 8-K was filed on November 10, 2025, announcing a conference call to discuss second-quarter fiscal year 2026 financial results.
- Correction: This amendment corrects the date of that conference call.
- Event Details: The conference call is now officially scheduled for November 17, 2025, at 11:30 AM EST.
This filing is procedural and ensures that investors have the correct information for the company's investor relations event. It does not reflect any change in the company's business operations, financial condition, or strategic direction.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.